Publication Plan. Within [***] ([***]) days after the Effective Date, each Party shall designate an individual to serve as that Party’s “Publication Manager.” The Parties shall, through the Publication Managers, cooperate in good faith and develop and execute a coordinated publication plan in or for the Territory that will include strategy, budget and policies for the publication activities related to the Products. The publication plan will also cover intended timing, venue, media, review, authors and other relevant considerations for each publication. The publication plan will be included in the Commercialization Plan for approval by the JSC. A Party may change its Publication Manager at any time upon written notice to the other Party.
Publication Plan. Subject to the terms of Section 12.7.2 (Publication Guidelines), each Party shall have the right to publish summaries of results of all Clinical Trials conducted by or on behalf of such Party during the Term with respect to a TAK-385 Licensed Product; provided, however, that the other Party shall have the right to review all such proposed publications prior to submission of such publication, and the proposing Party shall deliver to the other Party a copy of the proposed written publication at least [***] days prior to submission for publication, in order to review the Clinical Trial results and any and all such data which are the subject of such proposed publication in order to prepare any necessary Patent Office filings. The Parties shall discuss and reasonably cooperate in order to facilitate and ensure publication under this Section 12.7.1 (Publication Plan) of any such summaries of Clinical Trial data and results as required under Applicable Law on the Clinical Trial registry of each respective Party.
Publication Plan. Aim: The aim of the Publications Plan of the ROAMER project is to maximise the scientific impact of the project by facilitating the production of high quality scientific papers and reports in a timely manner and by disseminating them in the most efficient way and assuring the appropriate acknowledgement of authorship, collaboration and financial support.
Publication Plan. Publication of study results is addressed in the Clinical Trial Agreement with each site. All information and data, including the terms of this protocol, and all data, clinical results, and research conducted hereunder concerning XXXXX’s products and operations including VIVUS patent applications, formulas, manufacturing processes, basic scientific data, and formulation information that has been supplied by VIVUS and not previously published are considered confidential by XXXXX and will remain the sole property of XXXXX. The investigator understands and agrees that said proprietary and/or confidential information disclosed to or produced by him/her there under is highly valuable to VIVUS and will be used exclusively by the Investigator in accomplishing this clinical trial and will not be used for any other purposes.
Publication Plan. All Publications shall first be provided to BMS for review and comment at least thirty (30) days prior to submission for publication or other disclosure (including any abstract submission or patent application). At BMS’ request, Institution shall delete from the proposed Publication all specified BMS Confidential Information (except for relevant BMS Data). If BMS determines that such proposed Publication contains or may contain patentable subject matter, Institution shall delay such presentation, publication or other disclosure to allow sufficient time for the drafting and filing of a patent application directed to such subject matter. “
Publication Plan. Posting Research Protocol Prior to conducting the Research, Institution shall publish the Research Protocol on a publicly-available website. Institution agrees that BMS is free to use a cross-reference to the published Research Protocol and/or webpage on which it is posted (e.g., BMS is free to publish on its website a hyperlink to same).
Publication Plan. The publication plan will be developed in detail among the beneficiaries at the first year’s Summer School where the second project meeting will take place. In general, Gov 3.0 foresees the publication of 60 papers in esteemed conferences and journals with blind review procedures. Every academic partner (UAEGEAN, DUK, UNU, UiA, NEGZ) should initiate at least 12 papers during the project lifetime (or 4 per year) in order to fulfil the publications target. Cooperation and communication procedures have been set for the collaboration of the partners in joint publications. Every publication is advised to have representatives of at least two partners of the project. This target is close related with the workshop organisation target (15 workshops) in which the relative data for (a) drafting of the planned deliverables and (b) preparing research analyses for publications will be gathered. The publication plan of the Gov 3.0 project could be accessed by all partners and it is available at: xxxxx://xxxx.xxxxxx.xxx/spreadsheets/d/1RiN7WwZjBZEO2G1ACELhHPBlHuKYuNzjVJtWPE08lmc/edit#gid=2140872227
Publication Plan. Neither the complete nor any part of the results of the study carried out under this protocol, nor any of the information provided by the Sponsor for the purposes of performing the study, will be published or passed on to any third party without the written consent of Torax Medical. Any Investigator involved with this study is obligated to provide the Sponsor with complete test results and all data derived from the study. REFERENCES
Publication Plan. The Parties shall regularly consult (no less than [*]) and confer with respect to a global publication plan for Licensed Product with the understanding that neither Party can publish without the consent of the other Party. Should the Parties agree in writing that the publication with respect to Licensed Product by Amgen or Licensee is appropriate, then Amgen or Licensee, respectively, shall have the right to make such publication subject to Section 10.5.2 (Oversight and Review).
Publication Plan. The Parties shall share a publication plan covering a one year period through the JSC at least once in each Calendar Year. This plan shall include: (i) a list of planned Publications, and the dates, authors and brief summary of contents of such Publications; and (ii) a list of international congresses which the Party plans to attend (if the Party plans to communicate about the Product at such congress) both inside and outside the Party’s respective territory. If the Party that receives the publication plan believes that any of the planned Publications listed in the plan could reasonably be expected to have a material impact on the Product in such Party’s territory, it will (i) provide the Party that provided the plan with written notice which will identify such planned Publications which it requests to disclose to its sublicensees (including, with respect to ArQule, the ArQule Partner) and (ii) subject to the receipt by the notifying Party of the other Party’s written consent (such consent not to be unreasonably withheld or delayed), such Party will have the right to disclose the information in the plan about the Publications so identified to its sublicensees (including, with respect to ArQule, the ArQule Partner).
